Early Access Program Using Alpha 1 Antitrypsin Infusion for Patients With Steroid Refractory Acute GvHD After Hematopoietic Stem Cell Transplantation (HSCT)

NCT03172455 · clinicaltrials.gov ↗

NO_LONGER_AVAILABLE

Status

INDUSTRY

Sponsor class

Conditions

Acute-graft-versus-host Disease
Steroid Refractory Acute Graft Versus Host Disease
Graft-versus-host-disease
Graft Vs Host Disease
Alpha 1-Antitrypsin Deficiency
Alpha-1 Proteinase Inhibitor
Alpha-1 Protease Inhibitor Deficiency
Acute Graft-Versus-Host Reaction Following Bone Marrow Transplant

Interventions

DRUG: Glassia

Sponsor

Impatients N.V. trading as myTomorrows

Collaborators

[object Object]